Johan Nielsen-Vad

Arhus, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Diagnostic and Monitoring Strategies for VEXAS Syndrome: Evaluating Sanger Sequencing, NGS, and the SWIM-Score.

Diagnostic and Monitoring Strategies for VEXAS Syndrome: Evaluating Sanger Sequencing, NGS, and the SWIM-Score.

Journal: Journal of clinical immunology

Published: December 08, 2024

CRISPR activation to characterize splice-altering variants in easily accessible cells.

CRISPR activation to characterize splice-altering variants in easily accessible cells.

Journal: American journal of human genetics

Published: July 10, 2023

Genome-wide epigenetic and mRNA-expression profiling followed by CRISPR/Cas9-mediated gene-disruptions corroborate the MIR141/MIR200C-ZEB1/ZEB2-FGFR1 axis in acquired EMT-associated EGFR TKI-resistance in NSCLC cells.

Genome-wide epigenetic and mRNA-expression profiling followed by CRISPR/Cas9-mediated gene-disruptions corroborate the MIR141/MIR200C-ZEB1/ZEB2-FGFR1 axis in acquired EMT-associated EGFR TKI-resistance in NSCLC cells.

Journal: Translational lung cancer research

Published: July 07, 2022

EGFR transcription in non-small-cell lung cancer tumours can be revealed in ctDNA by cell-free chromatin immunoprecipitation (cfChIP).

EGFR transcription in non-small-cell lung cancer tumours can be revealed in ctDNA by cell-free chromatin immunoprecipitation (cfChIP).

Journal: Molecular oncology

Published: May 19, 2021

Cell-free Chromatin Immunoprecipitation (cfChIP) from blood plasma can determine gene-expression in tumors from non-small-cell lung cancer patients.

Cell-free Chromatin Immunoprecipitation (cfChIP) from blood plasma can determine gene-expression in tumors from non-small-cell lung cancer patients.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 18, 2020

The IFNL4 Gene Is a Noncanonical Interferon Gene with a Unique but Evolutionarily Conserved Regulation.

The IFNL4 Gene Is a Noncanonical Interferon Gene with a Unique but Evolutionarily Conserved Regulation.

Journal: Journal of virology

Published: September 09, 2019

Cause-and-Effect relationship between FGFR1 expression and epithelial-mesenchymal transition in EGFR-mutated non-small cell lung cancer cells.

Cause-and-Effect relationship between FGFR1 expression and epithelial-mesenchymal transition in EGFR-mutated non-small cell lung cancer cells.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 07, 2019

Up-Regulated FGFR1 Expression as a Mediator of Intrinsic TKI Resistance in EGFR-Mutated NSCLC.

Up-Regulated FGFR1 Expression as a Mediator of Intrinsic TKI Resistance in EGFR-Mutated NSCLC.

Journal: Translational oncology

Published: October 05, 2018

Simple method for assembly of CRISPR synergistic activation mediator gRNA expression array.

Simple method for assembly of CRISPR synergistic activation mediator gRNA expression array.

Journal: Journal of biotechnology

Published: November 18, 2017

MET amplification and epithelial-to-mesenchymal transition exist as parallel resistance mechanisms in erlotinib-resistant, EGFR-mutated, NSCLC HCC827 cells.

MET amplification and epithelial-to-mesenchymal transition exist as parallel resistance mechanisms in erlotinib-resistant, EGFR-mutated, NSCLC HCC827 cells.

Journal: Oncogenesis

Published: August 29, 2016

Golden Gate Assembly of CRISPR gRNA expression array for simultaneously targeting multiple genes.

Golden Gate Assembly of CRISPR gRNA expression array for simultaneously targeting multiple genes.

Journal: Cellular and molecular life sciences : CMLS

Published: March 26, 2016

Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients.

Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients.

Journal: Mediators of inflammation

Published: September 23, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026